NICE Technology Appraisals in the NHS in England: Area Team & CCG Level for MedTech & DebriSoft

The Innovation Scorecard aims to improve transparency within the NHS of what treatments recommended by NICE are available within Trusts and CCGs and at National and Area Team level. It is intended to support monitoring of compliance with NICE Technology Appraisal (TA) recommendations and to assist the NHS in the identification of variation, which can be explained, challenged or acted upon. It is not intended to be used for performance management.

The Innovation Health and Wealth Strategy set out plans to support development and adoption of innovation in the NHS. The National Institute for Health and Care Excellence (NICE) technology appraisal process assesses the clinical and cost effectiveness of new and existing medicines and treatments, and provides guidance on their use by the NHS.

There is no central collection of data which can directly support the assessment of uptake of NICE recommendations, nor is data on the number of patients treated available. Therefore this is an experimental publication, which makes use of data currently available from a range of sources, both from the NHS and the commercial sector. The HSCIC welcomes comments and suggestions from users to support future development of appropriate datasets and reporting.

Data and Resources

Additional Info

Field Value
Last Updated October 2, 2015, 11:50 (UTC)
Created January 26, 2015, 14:29 (UTC)
Theme Health